Dogecoin Cash, Inc. (OTCQB: DOGP) Subsidiary PrestoDoctor Expands Telehealth Cannabis Evaluations to Connecticut, Now Operating in 19 States Nationwide

Core Insights - PrestoDoctor, a subsidiary of Dogecoin Cash, Inc., is expanding its telemedicine services for medical cannabis evaluations to Connecticut, now operating in 19 states across the U.S. [1][4] - Since its launch in 2015, PrestoDoctor has served over 500,000 patients, establishing itself as a trusted platform for medical cannabis telehealth services [2][4]. - The Connecticut launch complies with state regulations that require certifications to be issued by licensed in-state clinicians, facilitating patient access to medical marijuana [3][6]. Company Overview - PrestoDoctor has been operational for 10 years, focusing on providing secure, patient-centered telehealth services [4][5]. - The platform offers flexible payment options, including traditional methods and select cryptocurrencies, reflecting a modern approach to healthcare solutions [4][8]. - The company emphasizes privacy and security in its telehealth workflows, consistent with its operations in other states [8]. Regulatory Compliance - The Connecticut launch aligns with state laws permitting telemedicine for medical marijuana certifications, ensuring that only licensed Connecticut professionals can issue certifications [3][6]. - Patients must complete the registration process with the Connecticut Department of Consumer Protection after receiving a certification [6].